MedTrace Logo

DARTS I Feasibility Study

NCT03035643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-08-20

No results posted yet for this study

Summary

The objective of this study is to investigate the feasibility and clinical benefits of the AMDS to treat patients with acute DeBakey type I dissections and/or intramural hematomas (IMH) involving the ascending aorta and aortic arch through open surgical repair.

Conditions

  • Aortic Dissection
  • Intramural Hematoma

Interventions

DEVICE

AMDS

The device will be implanted during an already planned surgical intervention for aortic dissection repair. The participant will be observed and data gathered during the surgery and routine standard of care follow up visits.

Sponsors & Collaborators

  • Artivion Inc.

    collaborator INDUSTRY

  • Ascyrus Medical LLC.

    lead INDUSTRY

Principal Investigators

  • Jessica Forcillo, MD · Centre Hospitalier de I'Universite de Montreal

  • Maral Ouzounian, MD · University Health Network - Toronto General Hospital

  • Michael Chu, MD · London Health Science Center

  • Philippe Demers · Montreal Heart Institute

  • Michael Moon, MD · University of Alberta

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-05
Primary Completion
2019-08-21
Completion
2024-03-19

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03035643 on ClinicalTrials.gov